Spartan’s technology has grown and changed to fit industry needs since the company’s inception in 2005. Below is a timeline of our accomplishments and milestones that has led to the creation of the Spartan Cube as you know it today.
Submitted the COVID-19 System to Health Canada for assessment to provide authorization to sell in Canada.
European Commercialization Launch: five distributors signed in Europe.
The TAILOR-PCI study is published in JAMA, featuring the use of the Spartan RX CYP2C19 Test.
Spartan Cube receives CE IVD Certification.
Spartan Cube is announced.
The Spartan Legionella Test launched.
Canada and Korea approve the Spartan RX CYP2C19 Test.
Spartan RX receives FDA clearance.
Spartan RX Technology used in POPular Genetics, 2,488 patient trial.
Spartan RX receives CE Marking for Europe, Africa, Asia.
Spartan RX CYP2C19 test introduced.
Spartan DX DNA Analyzer launched.
Spartan Bioscience founded.